Financial insights of CSBR

MyFinsight

For the quarter ending 2025-10-31, CSBR made $15,035K in revenue. $268K in net income. Net profit margin of 1.78%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-10-31	2025-07-31	2024-10-31	2024-07-31
Oncology revenue	15,035	13,995	13,489	14,061
Cost of oncology revenue	7,262	7,995	7,428	7,072
Research and development	2,616	2,082	1,689	1,454
Sales and marketing	1,998	1,855	1,751	1,679
General and administrative	2,974	2,570	1,889	2,527
Loss on disposal of equipment	0	-20	-	-
Total costs and operating expenses	14,850	14,522	12,757	12,732
Income (loss) from operations	185	-527	732	1,329
Other income, net	70	75	7	5
Income (loss) before provision for income taxes	255	-452	739	1,334
Provision for income taxes	18	14	11	21
Net income (loss)	237	-466	-	-
Less net loss attributable to noncontrolling interest	-31	-30	-	-
Net income (loss) attributable to company's common shares	268	-436	728	1,313

And diluted (in shares)	14,457,837	13,788,414	14,016,953	14,042,379
Basic (in dollars per share)	0.02	-0.03	0.05	0.1
Basic (in shares)	13,791,913	13,788,414	13,593,766	13,593,766
Diluted (in dollars per share)	0.02	-0.03	0.05	0.09